NJ

Natalie Johnston

Principal at 4BIO Capital

Greater London, England

Overview 

Natalie Johnston is currently a Principal at 4BIO Capital in Greater London, England, with a background in mammalian cell culture and cell biology. With experience as an Investment Analyst and Research Manager at GLG, she has a Doctor of Philosophy (Ph.D.) from Imperial College London and has worked as a Board Observer at Vianautis. Johnston's career highlights include her role as a Principal at 4BIO Capital, where she specializes in investing in Series A and Seed stage companies in the Therapeutics and BioTech sectors, showcasing expertise in research and data analysis.

Work Experience 

  • Principal

    2024 - Current

  • Associate

    2022 - 2024

  • Investment Analyst

    2019 - 2021

    4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector.

  • Board Observer

    2023

  • Research Manager

    2018 - 2019

  • Senior Research Associate | Healthcare

    2017 - 2018

    GLG (Gerson Lehrman Group, Inc.) is the world’s leading platform for professional learning. Business leaders, investors, consultants, social entrepreneurs, and other top professionals rely on GLG to learn in short- and long-term engagements from more than 425,000 members and other experts. Clients partner with GLG to address their most complex strategic challenges, make better business decisions, and advance their careers through conversations, mentorships, small group convenings, surveys, and other interactions—all within a rigorous compliance framework. Global, technology-driven, and nimble, GLG’s approximately 1,200 employees work in 22 offices in 12 countries.

  • Research Associate | Healthcare

    2016 - 2017

The world's insight network.

Raised $212,000,000.00 from SFW Capital Partners.

  • Biochemical Society Studentship

    2012 - 2012

    Awarded the Summer Vacation Studentship by the Biochemical Society U.K. - Completed a 6-week summer research project entitled ‘The functional anti-inflammatory consequences of AMPK activation in adipocytes’ under the supervision of Dr. Ian Salt, Institute of Cardiovascular & Medical Sciences, University of Glasgow. - Aimed to define whether AMPK activation in 3T3-L1 adipocytes alters MCP-1 secretion. - Project techniques: Mammalian cell culture and differentiation of adipocytes and macrophages, preparation of cell lysates, TCA precipitation of proteins, SDS-PAGE and immunoblotting and Chemotaxis assays. - Key skills learnt: Time-keeping and lab organisation, Image J computer programme, Adobe Photoshop, Microsoft Excel programming for statistical analysis.

Articles About Natalie

Relevant Websites